Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Initial Beneficial Ownership · 3

CS Diagnostics Corp.

Initial Beneficial Ownership

Filed Feb 4, 2026Accepted Feb 4, 2026, 2:00 PM ESTFiling CIK 1106861Accession 0001214659-26-001161
Share

Structured filing — 3

marketforms-72021.xml

Open full document ↗

Filing details

Report period
2025-12-31
Issuer
CS DIAGNOSTICS CORP.
Issuer CIK
0001106861
Trading symbol
CSDX

Reporting owner 1

Name
CS Interpharm LLC
Reporting owner CIK
0002104397
Relationship
10% owner
Address
1603 CAPITOL AVENUE, SUITE 413, CHEYENNE, WY, 82001

Non-derivative holdings

Non-derivative holdings · 1 reported row
SecurityAmount ownedOwnership
Common Stock49,362,500D
Table key
D
Direct

Signature 1

Signed
/s/ Mohammad Essayed
Date
2026-02-04

Company context

Current securities

Historical securities (6)

Recent company filings

  1. Non-Reliance on Previously Issued Financial Statements or a Related Audit ReportJun 23, 2026
  2. NT 10-Q filingMay 15, 2026
  3. 10-K filingApr 15, 2026
  4. NT 10-K filingMar 31, 2026
  5. 10-12G/A filingMar 12, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.